Chronic Fatigue Syndrome

Acheson E.D. (1959). The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease, and epidemic neuromyasthenia. Am. J. Med. 26:569–595.

AMERICAN PSYCHIATRIC ASSOCIATION DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS. (1987). (3rd ed. revised) DSM-III-R. Washington, DC.

Aoki T. , Usuda Y. , Miyakoshi H. , Tamura K. , and Herberman R.B. (1987). Low natural killer syndrome: Clinical and immunologic features. Nat. Immun. Cell Growth Regul. 6:116–128.

Archard L.C. , Bowles N.E. , Behan P.O. , Bell E.J. , and Doyle D. (1988). Postviral fatigue syndrome: Persistence of enterovirus RNA in muscle and elevated creatine kinase. J. Royal Soc. Med. 81:326–329.

Behan P.O. , Behan Wm.H. , and Bell E.J. (1985). The postviral fatigue syndrome-An analysis of the findings in 50 cases. J. Infect. 10:211–222.

Buchwald D. , Goldenberg D.L. , Sullivan J.L. , and Komaroff A.K. (1987a). The ‘chronic, active Epstein-Barr virus infection’ syndrome and fibromyalgia. Arthritis Rheum. 30:1132–1136.

Buchwald D. , Sullivan J.L. , and Komaroff A.L. (1987b). Frequency of ‘chronic active Epstein-Barr virus infection’ in a general medical practice. J.A.M.A. 257:2303–2307.

Buchwald D. and Komaroff A.K. (1991). Review of laboratory findings for patients with chronic fatigue syndrome. Rev. Infect. Dis. 13:S12–S18.

Buchwald D. , Cheney P.R. , Peterson D.L. , Henry B. , Wormsley S.B. , Geiger A. , Ablashi D.V. , Salahuddin S.Z. , Saxinger C. , Biddle R. , Kikinis R. , Jolesz F.A. , Folks T. , Balachandran N. , Gallo R.C. , and Komaroff A.L. (1992). A chronic illness characterized by fatigue, neurologic and immunologic disorders: Association with human herpesvirus-6. Ann. Intern. Med. (in press).

Byrne E. and Trounce I. (1987). Chronic fatigue and myalgia syndrome: Mitochrondrial and glycolytic studies in skeletal muscle. J. Neurol. Neurosurg. Psychiatry 50:743–746.

Caligiuri M. , Murray C. , Buchwald D. , Levine H. , Cheney P. , Peterson D. , Komaroff A.L. , and Ritz J. (1987). Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J. Immunol. 139:3306–3313.

Cheney P.R. , Dorman S.E. , and Bell D.S. (1989). Interleukin-2 and the chronic fatigue syndrome. Ann. Intern. Med. 110:321.

Denicoff K. , Rubinow D.R. , Pap M.Z. (1987). The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann. Intern. Med. 107:293–300.

Dubois R.E. , Seeley J.K. , Brus I. , Sakamoto K. , Ballow M. , Harada S. , Bechtold T.A. , Pearson G. , and Purtilo D.T. (1984). Chronic mononucleosis syndrome. South. Med. J. 77:1376–1382.

Gold D. , Bowden R. , Slxbey J. , Riggs R. , Katon W.J. , Ashley R. , Obrigewitch R. , and Corey L. (1990). Chronic fatigue: A prospective clinical and virologic study. J.A.M.A. 264:48–53.

Goldenberg D.L. , Simms R.W. , Geiger A. , and Komaroff A.K. (1990). High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum. 33:381–387.

Halpin D. and Wessely S. (1989). VP-1 antigen in chronic postviral fatigue syndrome. Lancet 1:1028–1029.

Hamblin T.J. , Hussain J. , Akbar A.N. , Tang Y.C. , Smith J.L. , and Jones D.B. (1983). Immunological reason for chronic ill health after infectious mononucleosis. Br. Med. J. 287:85–82.

Hellinger W.C. , Smith T.F. , Van Scoy R.E. , Spitzer P.G. , Forgacs P. , and Edson R.S. (1988). Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen. J.A.M.A. 260:971–973.

Ho-Yen D.O. , Carrington D. , and Armstrong A.A. (1988). Myalgic encephalitis and alpha-interferon. Lancet 1:125.

Holmes G.P. , Kaplan J.E. , Stewart J.A. , Hunt B. , Pinsky P.F. , and Schonberger L.B. (1987). A cluster of patients with a chronic mononucleosis-like syndrome: Is Epstein-Barr virus the cause? J.A.M.A. 257:2297–2302.

Holmes G.P. , Kaplan J.E. , Gantz N.M. (1988). Chronic fatigue syndrome: A working definition. Ann Intern Med. 108:387–389.

JAMAL G.A. and HANSEN S. (1985). Electrophysiological studies in the post-viral fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 48:691–694.

JONES J.F. , Ray G. , MINNICH L.L. , HICKS M.J. , KIBLER R. , and LOCAS D.O. (1985). Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: Elevated anti-early antigen antibodies. Ann. Intern. Med. 102:1–7.

JONES J.F. and STRAUS S.E. (1987). Chronic Epstein-Barr virus infection. Ann. Rev. Med. 38:195–209.

KASLOW J.E. , RUCKER L. , and ONISHI R. (1989). Liver extract-folic acid-cyanocobalamin vs. placebo for chronic fatigue syndrome. Arch Intern. Med. 149:2501.

KATON W.J. , BUCHWALD D.S. , SIMON G.E. , RUSSO J.E. , and MEASE P.J. (1991). Psychiatric illness in patients with chronic fatigue and rheumatoid arthritis. J. Gen. Intern. Med. 6:277–285.

KIBLER R. , LUCAS D.O. , HICKS M.J. , POULOS B.T. , and JONES J.F. (1985). Immune function in chronic active Epstein-Barr virus infection. J. Clin. Immunol. 5:46–54.

KLIMAS N.G. , SALVATO F.R. , MORGAN R. , and FLETCHER M.A. (1990). Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 28:1403–1410.

KOMAROFF A.K. and BUCHWALD D. (1991). Symptoms and signs of chronic fatigue syndrome. Rev. Infect. Dis. 13:S8–S11.

KROENKE K. , WOOD D.R. , MANGELSDORFF A.D. , NEIER N.J. , and POWELL J.B. (1988). Chronic fatigue in primary care: Prevalence, patient characteristics, and outcome. J.A.M.A. 260:929–934.

KRUESI M.J.P. , DALE J. , and STRAUS S.E. (1989). Psychiatric diagnoses in patients who have chronic fatigue syndrome. J. Clin. Psychiatry 50:53–56.

LAMY M.E. , FAVART A.M. , CORNU C. , MENDEZ M. , SEGAS M. , and BURTONBOY G. (1982). Study of Epstein Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti-EA and Ig anti-EBNA obtained with an original microliter technique: -Serological criterions of primary and recurrent EBV infections and follow-up of infectious mononucleosis; -Seroepidemiology of EBV in Belgium based on 5178 sera from patients. Acta. Clin. Belgica 37:281–298.

LINDE A. , HAMMARSTROM L. , and SMITH C.I.E. (1988). IgG subclass deficiency and chronic fatigue syndrome. Lancet 1:885–886.

LLOYD A.R. , HALES J.P. , and GANDEVIA S.C. (1988b). Muscle strength, endurance and recovery in the post-infection fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 51:1316–1322.

LLOYD A. , Abi H.D. , and WAKEFIELD D. (1988). Interferon and myalgic encephalomyelitis. Lancet 1:471.

LLOYD A.R. , WAKEFIELD D. , BOUGHTON C.R. , and DWYER J.M. (1989). Immunological abnormalities in the chronic fatigue syndrome. Med. J. Aust. 151:122–148.

MANU P. , LANE T.J. , and MATTHEWS D.A. (1988). The frequency of the chronic fatigue syndrome in patients with symptoms of persistent fatigue. Ann. Intern. Med. 109:554–556.

MANU P. , MATTHEWS D.A. , and LANE T.J. (1988b). The mental health of patients with a chief complaint of chronic fatigue: A prospective evaluation and follow-up. Arch. Intern. Med. 148:2213–2217.

MCDONALD E.M. , MANU A.H. , and THOMAS H.C. (1987). Interferons as mediators of psychiatric morbidity. Lancet 2:1175–1177.

MEDICAL STAFF OF THE ROYAL FREE HOSPITALS (1957). An outbreak of encephalomyelitis in the Royal Free Hospital Group, London, in 1955. Br. Med. J. 2:895–904.

MONTAGUE T.J. , MARRIE T.J. , KLASSEN G.A. , BERWICK D.J. , and HORACEK B.M. (1989). Cardiac function at rest and with exercise in the chronic fatigue syndrome. Chest 95:779–784.

MORAG A. , TOBI M. , RAVID Z. , REVEL M. , and SCHATTNER A. (1982). Increased (2′-5’)-oligo-a synthetase activity in patients with prolonged illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1:744.

MURDOCH J.C. (1988). Cell-mediated immunity in patients with myalgic encephalomyelitis syndrome. NZ. Med. J. 101:511–512.

OLSON G.B. , KANAAN M.N. , GERSUK G.M. , KELLEY L.M. , and JONES J.F. (1986). Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus infected patients. J. Allergy. Clin. Immunol. 78:308–314.

OLSON G.B. , KANAAN M.N. , KELLEY L.M. , and JONES J.F. (1986b). Specific allergen-induced Epstein-Barr nuclear antigen-positive B cells from patients with chronic-active Epstein-Barr virus infections. J. Allergy Clin. Immunol. 78:315–320.

ROBINS L.N. and HELZER J.E. (1985). Diagnostic Interview Schedule (DIS): Version III-A. St. Louis, Missouri: Dept. of Psychiatry, Washington Univ. School of Med.; May.

SALIT I.E. (1985). Sporadic postinfectious neuromyasthenia. Can. Med. Assoc. J. 4385;133:659–663.

STOKES M.J. , COOPER R.G. , and EDWARDS R.H.T. (1988). Normal muscle strength and fatigability in patients with effort syndromes. Br. Med. J. 297:1014–1017.

STRAUS S.E. , TOSATO G. , ARMSTRONG G. , LAWLEY T. , PREBLE O.T. , HENLE W. , DAVEY R. , PEARSON G. , EPSTEIN J. , BRUS I. , and BLAESE R.M. (1985). Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann. Int. Med. 102:7–16.

STRAUS S.E. , DALE J.K. , WRIGHT R. , and METCALFE D.D. (1988a). Allergy and the chronic fatigue syndrome. J. Allergy Clin. Immunol. 81:791–795.

STRAUS S.E. , DALE J.K. , TOBI M. (1988b). Acyclovir treatment of the chronic fatigue syndrome: Lack of efficacy in a controlled placebo trial. N. Engl. J. Med. 319:1692–1698.

SUBIRA M. , CASTILLA A. , CIREIRA M. , and PRIETO J. (1989). Deficient display of CD3 on lymphocytes of patients with chronic fatigue syndrome. J. Infect. Dis. 160:165–166.

TOBI M. , MORAG A. , RAVID Z. , CHOWERS I. , WEISS V.F. , MICHAELI Y. , BEN-CHETRIT E. , SHALIT M. , and KNOBLER H. (1982). Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1:61–64.

TOSATO G. , STRAUS S. , HENLE W. , PIKE S.E. , and BLAESE R.M (1985). Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J. Immunol. 134:3082–3088.

WAKEFIELD D. , LLOYD A. , and DWYER J. (1988). Human herpes virus 6 and myalgic encephalomyelitis. Lancet 1:1059.

WARNER C.L. , COOKFAIR D. , MEFFUER R. , BELL D. , Ley D. , and JACOBS L. (1989). Neurologic abnormalities in the chronic fatigue syndrome. Neurology 39 (suppl):420.

WESSELY S. and POWELL R. (1989). Fatigue syndromes: A comparison of chronic “postviral” fatigue with neuromuscular and affective disorders. J. Neurol. Neurosurg. Psychiatry 52:940–548.

YOUSEF G.E. , BELL E.J. , MANN G.F. , MURUGESAN V. , SMITH D.G. , MCCARTNEY R.A. , and MOWBRAY J.F. (1988). Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet 1:146–147.